BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 23286508)

  • 21. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
    Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL).
    Ellis KA; Szoeke C; Bush AI; Darby D; Graham PL; Lautenschlager NT; Macaulay SL; Martins RN; Maruff P; Masters CL; McBride SJ; Pike KE; Rainey-Smith SR; Rembach A; Robertson J; Rowe CC; Savage G; Villemagne VL; Woodward M; Wilson W; Zhang P; Ames D;
    Int Psychogeriatr; 2014 Apr; 26(4):543-54. PubMed ID: 24252258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting Stability of Mild Cognitive Impairment (MCI): Findings of a Community Based Sample.
    Ellendt S; Voβ B; Kohn N; Wagels L; Goerlich KS; Drexler E; Schneider F; Habel U
    Curr Alzheimer Res; 2017; 14(6):608-619. PubMed ID: 27978792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Framingham Risk Score and the Risk of Progression from Mild Cognitive Impairment to Dementia.
    Viticchi G; Falsetti L; Buratti L; Sajeva G; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
    J Alzheimers Dis; 2017; 59(1):67-75. PubMed ID: 28582863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test.
    Bolló-Gasol S; Piñol-Ripoll G; Cejudo-Bolivar JC; Llorente-Vizcaino A; Peraita-Adrados H
    Neurologia; 2014; 29(6):339-45. PubMed ID: 24139389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical and sociopsychological characteristics of older community residents with mild cognitive impairment as assessed by the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Kawai H; Hirano H; Yoshida H; Kojima M; Ihara K; Obuchi S
    J Geriatr Psychiatry Neurol; 2013 Dec; 26(4):209-20. PubMed ID: 23920040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Competing risk model based study of outcomes of mild cognitive impairment of seniors].
    Sun Q; Song Y; Kong P; Yu H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Mar; 36(3):241-4. PubMed ID: 25975401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study.
    Amieva H; Letenneur L; Dartigues JF; Rouch-Leroyer I; Sourgen C; D'Alchée-Birée F; Dib M; Barberger-Gateau P; Orgogozo JM; Fabrigoule C
    Dement Geriatr Cogn Disord; 2004; 18(1):87-93. PubMed ID: 15087583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors That a Diagnosis of Mild Cognitive Impairment Will Remain Stable 3 Years Later.
    Clem MA; Holliday RP; Pandya S; Hynan LS; Lacritz LH; Woon FL
    Cogn Behav Neurol; 2017 Mar; 30(1):8-15. PubMed ID: 28323681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of mild cognitive impairment to dementia due to AD in clinical settings.
    Tifratene K; Robert P; Metelkina A; Pradier C; Dartigues JF
    Neurology; 2015 Jul; 85(4):331-8. PubMed ID: 26136516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the utility of everyday memory test and the Alzheimer's Disease Assessment Scale-Cognitive part for evaluation of mild cognitive impairment and very mild Alzheimer's disease.
    Adachi H; Shinagawa S; Komori K; Toyota Y; Mori T; Matsumoto T; Sonobe N; Kashibayashi T; Ishikawa T; Fukuhara R; Ikeda M
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):148-53. PubMed ID: 23581865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOE and mild cognitive impairment: the Framingham Heart Study.
    Jefferson AL; Beiser AS; Seshadri S; Wolf PA; Au R
    Age Ageing; 2015 Mar; 44(2):307-11. PubMed ID: 25497326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment.
    Roalf DR; Quarmley M; Mechanic-Hamilton D; Wolk DA; Arnold SE; Moberg PJ;
    J Alzheimers Dis; 2016 Aug; 54(1):325-35. PubMed ID: 27567827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TeLPI performance in subjects with mild cognitive impairment and Alzheimer disease: a validation study.
    Alves L; Simões MR; Martins C; Freitas S; Santana I
    Alzheimer Dis Assoc Disord; 2013; 27(4):324-9. PubMed ID: 23314065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk profiles of subtypes of mild cognitive impairment: the sydney memory and ageing study.
    Sachdev PS; Lipnicki DM; Crawford J; Reppermund S; Kochan NA; Trollor JN; Draper B; Slavin MJ; Kang K; Lux O; Mather KA; Brodaty H;
    J Am Geriatr Soc; 2012 Jan; 60(1):24-33. PubMed ID: 22142389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.